DelveInsight's “Multiple System Atrophy Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Multiple System Atrophy, historical and ...

The Key Multiple System Atrophy Companies in the market include - Teva Pharmaceutical/MODAG GmBH, H. Lundbeck A/S/Genmab, Alterity Therapeutics, Theravance Biopharma, Ionis Pharmaceuticals, Inc ...

Dysautonomia may occur in association with a degenerative disorder of the central nervous system, as in multiple-system atrophy (also known as the Shy–Drager syndrome), 5 or may be due to ...

OBJECTIVES Urinary dysfunction and orthostatic hypotension are the prominent autonomic features in multiple system atrophy (MSA). A detailed questionnaire was given and autonomic function tests were ...

Each person with multiple sclerosis experiences it differently, but there are a few common complications. Read on to learn about these complications and ways to manage them.

The patterns of autonomic features in PD are different from other parkinsonian disorders. Detection of autonomic dysfunction may therefore be helpful in diagnosing PD in the early or pre-motor stages, ...

(UroToday.com) Dr. Lynn Stothers introduced a novel, transcutaneous optical monitoring system designed to track bladder volume and pressure in patients with neurogenic lower urinary tract dysfunction ...

Brain imaging in MSA revealed that distinct cerebellar and medullary atrophy patterns were closely linked to cardiovascular ...

Background Multiple system atrophy (MSA) is a sporadic late-onset progressive neurodegenerative disorder. [1] The prevalence of MSA is 1.9 to 4.9 in 100,000 people. [2, 3] MSA predominantly ...

Dr. Jason Kim and Dr. Steven Weissbart of the Women's Pelvic Health and Continence Center at Stony Brook University Hospital ...

This open-label study evaluated the safety and efficacy of intravenous immunoglobulin in treating multiple systems atrophy, a neurodegenerative disease for which there is currently no therapy.